OCSConference•globenewswire•
Oculis to Participate in Upcoming H.C Wainwright 5th Annual Ophthalmology Virtual Conference
Sentiment:Negative (30)
Summary
ZUG, Switzerland, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs, today announced that Oculis’ management will be participating in the H.C Wainwright 5th Annual Ophthalmology Virtual Conference on August 13, 2025.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 12, 2025 by globenewswire